Eva Barnett
Vermogen: 5 M $ op 30-09-2026
Vermogen: 5 M $ op 30-09-2026
Eva Renee Barnett worked at Eli Lilly & Co. from 2011 to 2012 as Chief Financial Officer-Austria & Switzerland.
From 2015 to 2021, worked at AbleTo, Inc. as Chief Integration Officer.
From 2021 to 2025, worked at Immunovant, Inc. as Chief Financial & Accounting Officer.
Education includes undergraduate studies at DePauw University and an MBA from Harvard Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMUNOVANT INC 0,08% | 30-06-2026 | 157.761 ( 0,08% ) | 5 M $ | 30-09-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOVANT, INC. | Financieel Directeur/CFO | 20-04-2025 |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Financieel Directeur/CFO | 01-03-2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-08-2012 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
AbleTo, Inc.
AbleTo, Inc. Medical/Nursing ServicesHealth Services Provides online therapy and coaching services for mental health conditions | Health Services |
DePauw University
DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau